Among more than 5,000 patients followed for a median of roughly 8 years, bilateral risk-reducing mastectomy (RRM) was ...
DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.
Progression-free survival was superior with first-line maintenance of palbociclib in HR-positive, HER2-positive metastatic ...
A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...
Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.
While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...
The Breast Cancer Coalition of Rochester has two grants it’s looking to award for research. Leaders at the BCCR said ...
Further research is needed to address racial disparities and optimize therapeutic approaches in breast cancer treatment.